These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6628547

  • 1. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C, Oblin A, Fage D, Scatton B.
    Eur J Pharmacol; 1983 Sep 16; 93(1-2):55-62. PubMed ID: 6628547
    [Abstract] [Full Text] [Related]

  • 2. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C, Fage D, Scatton B.
    Life Sci; 1984 Jan 23; 34(4):393-9. PubMed ID: 6694528
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 23; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 8. Cortical modulation of striatal function.
    Scatton B, Worms P, Lloyd KG, Bartholini G.
    Brain Res; 1982 Jan 28; 232(2):331-43. PubMed ID: 6200179
    [Abstract] [Full Text] [Related]

  • 9. Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.
    McIntyre IM, Kuhn C, Demitriou S, Fucek FR, Stanley M.
    Psychopharmacology (Berl); 1983 Jan 28; 81(2):150-4. PubMed ID: 6415746
    [Abstract] [Full Text] [Related]

  • 10. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C, Knaus GA, Auer B, Knaus HG, Haring C, Theodorsson E, Saria A.
    Synapse; 1990 Jan 28; 6(1):1-9. PubMed ID: 1697986
    [Abstract] [Full Text] [Related]

  • 11. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K, Unemi N, Segawa T.
    Arch Int Pharmacodyn Ther; 1985 Mar 28; 274(1):111-24. PubMed ID: 3925907
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H, Consolo S, Samanin R, Algeri S, Ponzio F.
    Adv Biochem Psychopharmacol; 1980 Mar 28; 24():259-65. PubMed ID: 7405665
    [No Abstract] [Full Text] [Related]

  • 13. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
    Reches A, Jackson-Lewis V, Fahn S.
    Psychopharmacology (Berl); 1984 Mar 28; 82(4):330-4. PubMed ID: 6427824
    [Abstract] [Full Text] [Related]

  • 14. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB, Rozitis A.
    Eur J Pharmacol; 1982 Feb 19; 78(1):113-5. PubMed ID: 7200429
    [Abstract] [Full Text] [Related]

  • 15. Poor evidence for depolarization block but uncoupling of nigral from striatal dopamine metabolism after chronic haloperidol treatment in the rat.
    Chrapusta SJ, Egan MF.
    J Neural Transm (Vienna); 2006 May 19; 113(5):573-82. PubMed ID: 16082510
    [Abstract] [Full Text] [Related]

  • 16. Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.
    Hanson GR, Alphs L, Wolf W, Levine R, Lovenberg W.
    J Pharmacol Exp Ther; 1981 Aug 19; 218(2):568-74. PubMed ID: 6166743
    [Abstract] [Full Text] [Related]

  • 17. Comparative effects of chronic haloperidol and sulpiride treatment on nigral and striatal GABA content.
    Nicoletti F, Patti F, Condorelli DF, Rampello L, Giammona G, Di Giorgio RM, Canonico PL, Scapagnini U.
    J Neurochem; 1981 Oct 19; 37(4):1048-51. PubMed ID: 7320718
    [Abstract] [Full Text] [Related]

  • 18. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E, Ceci A, Spinelli R, Samanin R.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2387-91. PubMed ID: 2886127
    [Abstract] [Full Text] [Related]

  • 19. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM, Nurk AM.
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov 15; 67(11):1606-10. PubMed ID: 6799331
    [Abstract] [Full Text] [Related]

  • 20. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA, Van Valkenburg CF, Belfroid RD, Heerkens CB.
    Eur J Pharmacol; 1988 Dec 06; 158(1-2):29-35. PubMed ID: 3220118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.